finally sold all my 21'$ChemoCentryx (CCXI.US)$calls and now am loading for the next breakthrough pharm plays$BeyondSpring (BYSI.US)$approval by nov 30, they were delayed just like ccxi and the drug plinabulin is a small cell lung cancer drug$Cortexyme (CRTX.US)$way oversold (from 121 to 12) when atuzaginstat "failed" its trial, but heres the catch, it worked. it proved to slow cognitive decline the trial was too broad so now they're starting a new narrower trial that they know they will pass and as always buying$Cleveland-Cliffs (CLF.US)$this is a long hold but will bounce to 28 quickly
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
iamiam
OPCat army
:
I have some subscription services, but the best is to just search the drugs and follow the rabbit hole beyond springs is Plinabulin or BP-2358 cortexyme drug is Atuzaginstat or COR388
iamiam
OPJamesfongmm
:
that depends on what your goals and risks are. if your goal is to invest, hold for a year or so, collect dividends and trim on peaks then $Cleveland-Cliffs (CLF.US)$ is the choice. if your risk can tollerate an 85% chance of approval and a big spike then $BeyondSpring (BYSI.US)$ is the one. I own all three of these
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Cat army : Thanks, can you share any link for the drug approval play? I am also thinking to shift from ccxi
iamiam OP Cat army : I have some subscription services, but the best is to just search the drugs and follow the rabbit hole
beyond springs is Plinabulin or BP-2358
cortexyme drug is Atuzaginstat or COR388
Cat army : I found it, thanks a lot! For beyond spring the fda approval can be a no also so it is risky
iamiam OP Cat army : it's always risky but my risk reward ratio allows it, pharm isn't for everyone and it's always ok to hedge
Cat army iamiam OP : Thanks again!
iamiam OP : your welcome
Jamesfongmm : So buy BYSI or CLF?
iamiam OP Jamesfongmm : that depends on what your goals and risks are. if your goal is to invest, hold for a year or so, collect dividends and trim on peaks then $Cleveland-Cliffs (CLF.US)$ is the choice. if your risk can tollerate an 85% chance of approval and a big spike then $BeyondSpring (BYSI.US)$ is the one. I own all three of these
Cat army iamiam OP : Are you sure there is an 85% chance of approval?
Jamesfongmm iamiam OP : Any recommended price to ender?
View more comments...